Moneycontrol Podcast
/
The Market Podcast | Why pharma is back in favour; don't value IRCTC and D-Mart by traditional parameters
Our original embed player - you can use this to maintain continuity with any other episodes you've already embedded. Otherwise we'd suggest
upgrading to our new player.